Takeda Pharmaceutical Co. Ltd (TAK)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2025 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Sell 100.00% | 522,030 | 0.16 | |
| Q4 2024 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 59.25% | 759,162 | 0.23 | |
| Q3 2024 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 5.39% | 72,972 | 0.03 | |
| Q2 2024 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 6.28% | 90,744 | 0.03 | |
| Q2 2023 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 0.78% | 8,782 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 15.09% | 200,676 | 0.08 | |
| Q1 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 716,145 | 0.21 | |
| Q4 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 6.31% | 48,256 | 0.01 | |
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 9,434,803 | 1.91 | |
| Q3 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 54.58% | 918,487 | 0.23 | |
| ≡ | Seth Klarman - Baupost Group | Reduce 0.03% | 3,200 | 0.00 | |
| Q2 2019 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 11.54% | 1,231,018 | 0.20 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 3.37% | 58,778 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.